“Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated With Thrombopoietin Receptor Agonists”. 2023. Mediterranean Journal of Hematology and Infectious Diseases 15 (1): e2023021. https://doi.org/10.4084/MJHID.2023.021.